# Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

> **NCT01575275** · PHASE2 · TERMINATED · sponsor: **Michael Vogelbaum, MD, PhD** · enrollment: 8 (actual)

## Conditions studied

- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Recurrent Adult Brain Tumor

## Interventions

- **DRUG:** aminolevulinic acid
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT01575275
- **Lead sponsor:** Michael Vogelbaum, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Drugs unavailable
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575275, "Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01575275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*